These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38845130)

  • 1. Racial and geographic disparities in global prurigo nodularis clinical trials.
    Dagenet CB; Saadi C; Phillips MA; Price KN; Tong L; Hsiao JL; Shi VY
    Int J Dermatol; 2024 Jun; ():. PubMed ID: 38845130
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial disparities in mortality among patients with prurigo nodularis: A multi-center cohort study.
    Sutaria N; Adawi W; Brown I; Parthasarathy V; Roh YS; Choi J; Bordeaux ZA; Trinh P; Le TK; Deng J; Semenov YR; Kwatra SG
    J Am Acad Dermatol; 2022 Feb; 86(2):487-490. PubMed ID: 34560195
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to: "Racial disparities in mortality among patients with prurigo nodularis: A multi-center cohort study".
    Trepanowski N; Huang L; Hartman RI
    J Am Acad Dermatol; 2022 Sep; 87(3):e113. PubMed ID: 35577230
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding racial disparities in prurigo nodularis.
    Sutaria N; Semenov YR; Kwatra SG
    J Am Acad Dermatol; 2022 Sep; 87(3):e111-e112. PubMed ID: 35577228
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis.
    Kwatra SG; Rodriguez D; Dias-Barbosa C; Budhiarso I; Fofana F; Vernon M; Gabriel S; Piketty C; Puelles J
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2403-2416. PubMed ID: 37615836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Sleep Disturbance Numerical Rating Scale: Content Validity, Psychometric Validation, and Meaningful Within-Patient Change in Prurigo Nodularis.
    Ständer S; Fofana F; Dias-Barbosa C; Rodriguez D; Budhiarso I; Jabbar-Lopez ZK; Piketty C; Vernon M; Puelles J
    Dermatol Ther (Heidelb); 2023 Jul; 13(7):1587-1602. PubMed ID: 37329468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
    Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
    N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study.
    Sofen H; Bissonnette R; Yosipovitch G; Silverberg JI; Tyring S; Loo WJ; Zook M; Lee M; Zou L; Jiang GL; Paolini JF
    EClinicalMedicine; 2023 Mar; 57():101826. PubMed ID: 36816342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prurigo nodularis: a review.
    Lee MR; Shumack S
    Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid and prurigo nodularis.
    Roenigk RK; Dahl MV
    J Am Acad Dermatol; 1986 May; 14(5 Pt 2):944-7. PubMed ID: 3519701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tofacitinib for Prurigo Nodularis: A Case Report.
    Peng C; Li C; Zhou Y; Wang Q; Xie P; Li T; Hao P
    Clin Cosmet Investig Dermatol; 2022; 15():503-506. PubMed ID: 35340735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis.
    Ständer S; Ketz M; Kossack N; Akumo D; Pignot M; Gabriel S; Chavda R
    Acta Derm Venereol; 2020 Nov; 100(18):adv00309. PubMed ID: 33021323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prurigo nodularis: Pathogenesis and management.
    Williams KA; Huang AH; Belzberg M; Kwatra SG
    J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prurigo nodularis: its association with dermatoses and systemic disorders].
    Mettang T; Vonend A; Raap U
    Hautarzt; 2014 Aug; 65(8):697-703. PubMed ID: 25113328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis.
    Harris B; Harris K; Penneys NS
    J Am Acad Dermatol; 1992 Jan; 26(1):56-8. PubMed ID: 1732336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermoscopy of prurigo nodularis.
    Errichetti E; Piccirillo A; Stinco G
    J Dermatol; 2015 Jun; 42(6):632-4. PubMed ID: 25808786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merkel cells and prurigo nodularis.
    Nahass GT; Penneys NS
    J Am Acad Dermatol; 1994 Jul; 31(1):86-8. PubMed ID: 7517411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phototherapy for Prurigo Nodularis: Our Experience and a Review of the Literature.
    Arrieta A; Jaka A; Del Alcázar E; Blanco M; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2021 Apr; 112(4):339-344. PubMed ID: 33221272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis.
    Shintani T; Ohata C; Koga H; Ohyama B; Hamada T; Nakama T; Furumura M; Tsuruta D; Ishii N; Hashimoto T
    Dermatol Ther; 2014; 27(3):135-9. PubMed ID: 24102897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide.
    Lan CC; Lin CL; Wu CS; Chai CY; Chen WT; Chen GS
    J Dermatol; 2007 Apr; 34(4):237-42. PubMed ID: 17352720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.